Parkman Healthcare Partners LLC Keros Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 421,782 shares of KROS stock, worth $8.19 Million. This represents 3.46% of its overall portfolio holdings.

Number of Shares

421,782

Previous 198,627 112.35%

Holding current value

$8.19 Million

Previous $9.08 Million 169.82%

% of portfolio

3.46%

Previous 1.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.68 - $58.07 $9.3 Million - $13 Million	223,155 Added 112.35%	421,782 $24.5 Million
Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $904,617 - $1.36 Million	20,292 Added 11.38%	198,627 $9.08 Million
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $7.51 Million - $12.8 Million	-182,132 Reduced 50.53%	178,335 $11.8 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $1.68 Million - $2.54 Million	61,992 Added 20.77%	360,467 $14.3 Million
Q3 2023 Nov 14, 2023	BUY	$31.57 - $43.02 $683,806 - $931,813	21,660 Added 7.82%	298,475 $9.52 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $3.63 Million - $4.97 Million	97,525 Added 54.4%	276,815 $11.1 Million
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $2.18 Million - $3.11 Million	52,500 Added 41.41%	179,290 $7.66 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $1.06 Million - $1.39 Million	26,863 Added 26.88%	126,790 $6.09 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $1.45 Million - $2.09 Million	52,139 Added 109.1%	99,927 $3.76 Million
Q2 2022 Aug 12, 2022	SELL	$26.03 - $67.04 $648,199 - $1.67 Million	-24,902 Reduced 34.26%	47,788 $1.32 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $119,157 - $167,929	2,829 Added 4.05%	72,690 $3.95 Million
Q4 2021 Feb 11, 2022	BUY	$36.95 - $62.89 $2.58 Million - $4.39 Million	69,861 New	69,861 $4.09 Million

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $500M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Keros Therapeutics, Inc. Transaction History